ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹990 Cr | ₹732 Cr | ₹753 Cr | ₹801 Cr | ₹656 Cr |
What is the latest Contingent Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹990 Cr |
| Mar2025 | ₹732 Cr |
| Mar2024 | ₹753 Cr |
| Mar2023 | ₹801 Cr |
| Mar2022 | ₹656 Cr |
How is Contingent Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹990 Cr | 35.27 | |
| Mar2025 | ₹732 Cr | -2.84 | |
| Mar2024 | ₹753 Cr | -5.98 | |
| Mar2023 | ₹801 Cr | 22.19 | |
| Mar2022 | ₹656 Cr | - | |
Compare Contingent Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹111,959.4 Cr | 0.8% | 0.9% | 15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 0.8% |
0.9% |
15% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses